| Symbol |
Name |
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACO1
|
aconitase 1, soluble
|
|
ACTB
|
actin, beta
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTR1A
|
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast)
|
|
ACVR1
|
activin A receptor, type I
|
|
ACYP2
|
acylphosphatase 2, muscle type
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAP1
|
ArfGAP with dual PH domains 1
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AFG3L2
|
AFG3-like AAA ATPase 2
|
|
AGA
|
aspartylglucosaminidase
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKIP1
|
A kinase (PRKA) interacting protein 1
|
|
AKR1D1
|
aldo-keto reductase family 1, member D1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ALAD
|
aminolevulinate dehydratase
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ALB
|
albumin
|
|
ALDOA
|
aldolase A, fructose-bisphosphate
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOXE3
|
arachidonate lipoxygenase 3
|
|
ALPP
|
alkaline phosphatase, placental
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMH
|
anti-Mullerian hormone
|
|
ANAPC16
|
anaphase promoting complex subunit 16
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARX
|
aristaless related homeobox
|
|
ASL
|
argininosuccinate lyase
|
|
ASPA
|
aspartoacylase
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATD
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP5J
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKA
|
aurora kinase A
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
AVIL
|
advillin
|
|
B2M
|
beta-2-microglobulin
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BBS2
|
Bardet-Biedl syndrome 2
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BCS1L
|
BC1 (ubiquinol-cytochrome c reductase) synthesis-like
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BHLHB9
|
basic helix-loop-helix domain containing, class B, 9
|
|
BICC1
|
BicC family RNA binding protein 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BP33
|
Blood pressure QTL 33
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BSND
|
barttin CLCNK-type chloride channel accessory beta subunit
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTG2
|
BTG family, member 2
|
|
BTN3A1
|
butyrophilin, subfamily 3, member A1
|
|
C11ORF72
|
chromosome 11 open reading frame 72
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1S
|
complement component 1, s subcomponent
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1
|
|
CAGE1
|
cancer antigen 1
|
|
CALCRL
|
calcitonin receptor-like
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCNA1
|
cyclin A1
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD163
|
CD163 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD84
|
CD84 molecule
|
|
CD9
|
CD9 molecule
|
|
CD99
|
CD99 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK20
|
cyclin-dependent kinase 20
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM16
|
carcinoembryonic antigen-related cell adhesion molecule 16
|
|
CEMIP
|
cell migration inducing protein, hyaluronan binding
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRND
|
cholinergic receptor, nicotinic, delta (muscle)
|
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLU
|
clusterin
|
|
CNN1
|
calponin 1, basic, smooth muscle
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX2
|
|
|
CPA6
|
carboxypeptidase A6
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSNK1G1
|
casein kinase 1, gamma 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSNK2A2
|
casein kinase 2, alpha prime polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSS
|
cathepsin S
|
|
CTTN
|
cortactin
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DCTN1
|
dynactin 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DHFR
|
dihydrofolate reductase
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DISP1
|
dispatched homolog 1 (Drosophila)
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DMRT1
|
doublesex and mab-3 related transcription factor 1
|
|
DNAJC13
|
DnaJ (Hsp40) homolog, subfamily C, member 13
|
|
DNM1
|
dynamin 1
|
|
DOCK10
|
dedicator of cytokinesis 10
|
|
DOCK3
|
dedicator of cytokinesis 3
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPY19L2
|
dpy-19-like 2 (C. elegans)
|
|
DPYSL5
|
dihydropyrimidinase-like 5
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX2
|
dual oxidase 2
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDA
|
ectodysplasin A
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELOVL1
|
ELOVL fatty acid elongase 1
|
|
ENG
|
endoglin
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
|
EP300
|
E1A binding protein p300
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPB42
|
erythrocyte membrane protein band 4.2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETFB
|
electron-transfer-flavoprotein, beta polypeptide
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
|
EYA4
|
EYA transcriptional coactivator and phosphatase 4
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FBN1
|
fibrillin 1
|
|
FCRL4
|
Fc receptor-like 4
|
|
FGB
|
fibrinogen beta chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGG
|
fibrinogen gamma chain
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKRP
|
fukutin related protein
|
|
FKTN
|
fukutin
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMNL1
|
formin-like 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP2
|
forkhead box P2
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FTL
|
ferritin, light polypeptide
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FXN
|
frataxin
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
GABPB1
|
GA binding protein transcription factor, beta subunit 1
|
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALK1
|
galactokinase 1
|
|
GALR2
|
galanin receptor 2
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAR1
|
GAR1 ribonucleoprotein
|
|
GATA2
|
GATA binding protein 2
|
|
GBA
|
glucosidase, beta, acid
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRB
|
glycine receptor, beta
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GORASP2
|
golgi reassembly stacking protein 2, 55kDa
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPC3
|
glypican 3
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2E2
|
general transcription factor IIE, polypeptide 2, beta 34kDa
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBG2
|
hemoglobin, gamma G
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC8
|
histone deacetylase 8
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST2H2BE
|
histone cluster 2, H2be
|
|
HK1
|
hexokinase 1
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HMGN2
|
high mobility group nucleosomal binding domain 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HRH4
|
histamine receptor H4
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HUWE1
|
HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
|
|
IAPP
|
islet amyloid polypeptide
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDH3B
|
isocitrate dehydrogenase 3 (NAD+) beta
|
|
IDS
|
iduronate 2-sulfatase
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INSR
|
insulin receptor
|
|
IRAK2
|
interleukin-1 receptor-associated kinase 2
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA0319
|
KIAA0319
|
|
KIF11
|
kinesin family member 11
|
|
KIF1A
|
kinesin family member 1A
|
|
KIF2C
|
kinesin family member 2C
|
|
KIF6
|
kinesin family member 6
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF6
|
Kruppel-like factor 6
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LARGE
|
like-glycosyltransferase
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIMK2
|
LIM domain kinase 2
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LMBR1
|
limb development membrane protein 1
|
|
LMNA
|
lamin A/C
|
|
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARVELD2
|
MARVEL domain containing 2
|
|
MB
|
myoglobin
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MCCC1
|
methylcrotonoyl-CoA carboxylase 1 (alpha)
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEFV
|
Mediterranean fever
|
|
MEIS1
|
Meis homeobox 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MIR132
|
microRNA 132
|
|
MIR204
|
microRNA 204
|
|
MIR20A
|
microRNA 20a
|
|
MIR34A
|
microRNA 34a
|
|
MIR93
|
microRNA 93
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPZ
|
myelin protein zero
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT-ATP8
|
ATP synthase F0 subunit 8
|
|
MT-ND3
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
MT-ND4L
|
NADH dehydrogenase, subunit 4L (complex I)
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT-TF
|
tRNA
|
|
MT-TI
|
tRNA
|
|
MT-TL1
|
tRNA
|
|
MT-TQ
|
tRNA
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
ND1
|
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NEK8
|
NIMA-related kinase 8
|
|
NELFA
|
negative elongation factor complex member A
|
|
NELFB
|
negative elongation factor complex member B
|
|
NELFCD
|
negative elongation factor complex member C/D
|
|
NELFE
|
negative elongation factor complex member E
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NFAM1
|
NFAT activating protein with ITAM motif 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRD1
|
nardilysin (N-arginine dibasic convertase)
|
|
NRXN1
|
neurexin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUB1
|
negative regulator of ubiquitin-like proteins 1
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OPN1LW
|
opsin 1 (cone pigments), long-wave-sensitive
|
|
OPN1MW
|
opsin 1 (cone pigments), medium-wave-sensitive
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRL1
|
opiate receptor-like 1
|
|
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin
|
|
OSBPL3
|
oxysterol binding protein-like 3
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
PACRG
|
PARK2 co-regulated
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PAX9
|
paired box 9
|
|
PCDH15
|
protocadherin-related 15
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHB
|
pyruvate dehydrogenase (lipoamide) beta
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDZK1IP1
|
PDZK1 interacting protein 1
|
|
PER2
|
period circadian clock 2
|
|
PEX2
|
peroxisomal biogenesis factor 2
|
|
PFKP
|
phosphofructokinase, platelet
|
|
PGAM5
|
phosphoglycerate mutase family member 5
|
|
PGF
|
placental growth factor
|
|
PGRMC2
|
progesterone receptor membrane component 2
|
|
PHB
|
prohibitin
|
|
PHB2
|
prohibitin 2
|
|
PHF6
|
PHD finger protein 6
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PHPT1
|
phosphohistidine phosphatase 1
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIDD1
|
p53-induced death domain protein 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLA2G15
|
phospholipase A2, group XV
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
PLK2
|
polo-like kinase 2
|
|
PLP1
|
proteolipid protein 1
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POMGNT1
|
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
|
|
PON2
|
paraoxonase 2
|
|
PORCN
|
porcupine homolog (Drosophila)
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPAP2B
|
phosphatidic acid phosphatase type 2B
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIP5K2
|
diphosphoinositol pentakisphosphate kinase 2
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRG4
|
proteoglycan 4
|
|
PRIMPOL
|
primase and polymerase (DNA-directed)
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRNP
|
prion protein
|
|
PROS1
|
protein S (alpha)
|
|
PSAP
|
prosaposin
|
|
PSD4
|
pleckstrin and Sec7 domain containing 4
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRT
|
protein tyrosine phosphatase, receptor type, T
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAE1
|
ribonucleic acid export 1
|
|
RAI1
|
retinoic acid induced 1
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RASD1
|
RAS, dexamethasone-induced 1
|
|
RB1
|
retinoblastoma 1
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RECQL
|
RecQ helicase-like
|
|
RET
|
ret proto-oncogene
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
RNF13
|
ring finger protein 13
|
|
RNF167
|
ring finger protein 167
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
RNU4ATAC
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RS1
|
retinoschisin 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR5
|
sphingosine-1-phosphate receptor 5
|
|
SAA1
|
serum amyloid A1
|
|
SAA@
|
serum amyloid A1 cluster
|
|
SACS
|
sacsin molecular chaperone
|
|
SCAP
|
SREBF chaperone
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SEPN1
|
selenoprotein N, 1
|
|
SEPT4
|
septin 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SETD2
|
SET domain containing 2
|
|
SF1
|
splicing factor 1
|
|
SFN
|
stratifin
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFTPD
|
surfactant protein D
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC26A8
|
solute carrier family 26 (anion exchanger), member 8
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SLU7
|
SLU7 splicing factor homolog (S. cerevisiae)
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SOAT2
|
sterol O-acyltransferase 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPAST
|
spastin
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
|
|
STAG2
|
stromal antigen 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STC2
|
stanniocalcin 2
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAS2R14
|
taste receptor, type 2, member 14
|
|
TBX21
|
T-box 21
|
|
TBX3
|
T-box 3
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF12
|
transcription factor 12
|
|
TCF3
|
transcription factor 3
|
|
TCF4
|
transcription factor 4
|
|
TECTA
|
tectorin alpha
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
THBD
|
thrombomodulin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNXB
|
tenascin XB
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP53AIP1
|
tumor protein p53 regulated apoptosis inducing protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPO
|
thyroid peroxidase
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRB
|
T cell receptor beta locus
|
|
TREML2
|
triggering receptor expressed on myeloid cells-like 2
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TUB
|
tubby bipartite transcription factor
|
|
TUSC5
|
tumor suppressor candidate 5
|
|
TYMP
|
thymidine phosphorylase
|
|
UBAP1
|
ubiquitin associated protein 1
|
|
UBC
|
ubiquitin C
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
USP20
|
ubiquitin specific peptidase 20
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VILL
|
villin-like
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WDR72
|
WD repeat domain 72
|
|
WNK2
|
WNK lysine deficient protein kinase 2
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WT1
|
Wilms tumor 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
XYLT1
|
xylosyltransferase I
|
|
XYLT2
|
xylosyltransferase II
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YPEL3
|
yippee-like 3 (Drosophila)
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZNF350
|
zinc finger protein 350
|
|
ZNF703
|
zinc finger protein 703
|
